BioCardia Inc (BCDA) is not a strong buy for a beginner, long-term investor at this time. The stock lacks significant positive catalysts, has weak financial performance, and no strong trading signals. While insider buying is a positive factor, the overall technical and financial indicators do not support a compelling investment case.

Technical Analysis

The MACD is positive and expanding, indicating a slight bullish momentum. However, the RSI is neutral at 67.92, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.196, with resistance at 1.28 and support at 1.112. Overall, the technical indicators suggest a weak trend with no clear upward momentum.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Insiders are buying, with a 373.20% increase in buying activity over the last month.

Neutral/Negative Catalysts

No recent news or events to drive positive sentiment. Financial performance is weak, with declining net income, EPS, and gross margin. No significant hedge fund activity or congress trading data.

Financial Performance

In Q3 2025, revenue remained at 0 with no growth. Net income dropped by -14.62% YoY to -$1,483,000, EPS fell by -60.66% YoY to -0.24, and gross margin dropped to 0, down -100.00% YoY. The financials indicate a struggling company with no signs of improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

2 Analyst Rating

Wall Street analysts forecast BCDA stock price to rise

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.290

Low

Averages

15.5

High